Dr Reddys Laboratories Share Price Today - Live Blog for December 16, 2025

With a -0.11% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,273.80. The stock is currently trading at a PE of 18.6300, while the industry PE is 33.2891, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd stock price decreased by -0.13%, with the current market value at ₹1,274.65 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd observed a -0.29% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,276.30. The stock has a PE ratio of 18.6300, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.08% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,280.20 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price remained the same, currently trading at ₹1,280.00. This unchanging trend might prompt investors to reevaluate their investment thesis and consider factors influencing the stock's stability.

The share price of Dr Reddys Laboratories Ltd remained fixed, with no fluctuations, and is currently at ₹1,280.05. Investors may choose to investigate the factors contributing to this price stability and whether it presents an investment opportunity.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.05% in its share price, and it currently trades at ₹1,280.00 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd stock maintained its current value, with no movement, and is trading at ₹1,280.60. The stock has a PE ratio of 18.6300, an ROE of 16.0277%, and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.05%, and as of now, it's trading at ₹1,280.80 per share. This upward trajectory is attracting keen interest from investors.

With a -0.02% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,279.70. The stock is currently trading at a PE of 18.6300, while the industry PE is 33.2891, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd's share price remained the same, currently trading at ₹1,280.00. This unchanging trend might prompt investors to reevaluate their investment thesis and consider factors influencing the stock's stability.

Dr Reddys Laboratories Ltd experienced a substantial 0.01% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,280.00, making it an appealing option for investors.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.05% boost, with the current market value at ₹1,280.45 per share. This surge has not gone unnoticed by investors.

Dr Reddys Laboratories Ltd observed a remarkable 0.27% surge in its share price and is presently trading at ₹1,280.00. The increased investor interest is driving this surge.

After a notable 0.01% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,276.10. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277%.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.00%. At this moment, it's actively trading at ₹1,276.00, presenting an enticing opportunity for those in the market.

The stock of Dr Reddys Laboratories Ltd suffered a -0.04% drop, and it's now trading at ₹1,275.95 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

The share price of Dr Reddys Laboratories Ltd remained stagnant, with no fluctuations. It is currently at ₹1,276.40. Investors may use this stability as an opportunity to reevaluate their portfolios and risk tolerance.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.05%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,275.65 per share.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.05% upswing, and it's currently trading at ₹1,275.20 per share. Investors are closely watching this development.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.08% in its share price, and it currently trades at ₹1,274.00 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

With a -0.08% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,274.00. The stock is currently trading at a PE of 18.6300, while the industry PE is 33.2891, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd experienced a -0.21% dip in its share price and is currently trading at ₹1,274.40. The stock has a PE ratio of 18.6300, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.19%. At this moment, it's actively trading at ₹1,277.00, presenting an enticing opportunity for those in the market.

The stock of Dr Reddys Laboratories Ltd suffered a -0.09% drop, and it's now trading at ₹1,274.60 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.33%, signalling a challenging period. Currently trading at ₹1,275.80, this stock has caught the eye of bargain hunters, who may be considering their entry points.

With a -0.33% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,275.80. Investors should examine the factors driving this decline. The stock's PE ratio is 18.6300, whereas the industry PE ratio stands at 33.2891.